PMID: 8455045Mar 1, 1993Paper

Selection to postmenopausal therapy by women's characteristics

Journal of Clinical Epidemiology
E HemminkiP Topo

Abstract

Many surveys have shown that women using postmenopausal hormone therapy have a lower incidence of cardiovascular diseases and lower overall mortality. The purpose of this study was to compare past and non-users with current users of hormone therapy in regard to characteristics known to, or assumed to, predict poor subsequent health (indicators). The main data source was a survey in 1989 of a random sample (n = 2000, 86% response rate) of 45-64 year-old Finnish women. Among women with their uterus, after adjusting for age and urbanism, of the 21 indicators studied, 10 suggested a poorer and none a better health prognosis for the non-users than for current users. Many differences were greater among older women, suggesting a cohort effect or long-term users being an especially selected group. Among hysterectomized women, differences between users and non-users were similar or smaller than among women with uteri. The past users were more similar to non-users than current users. Our study suggests that women with a better health prognosis are selected or select themselves for hormone therapy, and that may impede interpretation of observational studies on hormone therapy and health.

References

Jun 3, 1976·The New England Journal of Medicine·L RosenbergH Jick
Sep 14, 1979·JAMA : the Journal of the American Medical Association·D B PetittiS Ramcharan
Nov 1, 1976·Social Science & Medicine·E SingerL Srole
Jan 1, 1992·Cancer Causes & Control : CCC·H O Adami
Dec 1, 1991·Journal of Epidemiology and Community Health·P TopoA Uutela
Jan 1, 1991·Archives of Internal Medicine·B E HendersonR K Ross
Jan 1, 1991·Journal of Clinical Epidemiology·L K HeilbrunJ M Vogel
Apr 10, 1991·JAMA : the Journal of the American Medical Association·E Barrett-Connor, T L Bush
Oct 13, 1990·BMJ : British Medical Journal·A RissanenJ Maatela
Oct 1, 1990·American Journal of Public Health·R B HarrisW L Haskell
Mar 1, 1988·Preventive Medicine·V L ErnsterD Schottenfeld
Apr 14, 1989·JAMA : the Journal of the American Medical Association·E Barrett-ConnorM H Criqui
Sep 3, 1988·BMJ : British Medical Journal·R Beaglehole
Oct 29, 1988·BMJ : British Medical Journal
Jul 1, 1988·Preventive Medicine·G M EgelandS F Kelsey
Aug 6, 1988·BMJ : British Medical Journal·A GreenK Moser
Mar 1, 1987·Controlled Clinical Trials·R B Haynes, R Dantes
Mar 1, 1987·Journal of Epidemiology and Community Health·G GreenbergT W Meade
Mar 1, 1987·American Journal of Public Health·J KaprioH Rita
Oct 24, 1985·The New England Journal of Medicine·M J StampferC H Hennekens
Feb 1, 1984·Annals of Internal Medicine·A P Simopoulos, T B Van Itallie
Jan 1, 1983·Acta Obstetricia Et Gynecologica Scandinavica·I PerssonP Manell
Aug 1, 1982·American Journal of Public Health·J M Mossey, E Shapiro
May 30, 1964·British Medical Journal·R DOLL, A B HILL

❮ Previous
Next ❯

Citations

Mar 12, 2009·Age·Sanjay AsthanaUNKNOWN Cognitive Aging Work Group
Dec 10, 2003·Obstetrics and Gynecology·Kate M Brett, Cynthia A Reuben
Oct 31, 1997·The American Journal of Medicine·V W Henderson
Jul 1, 1997·The American Journal of Medicine·W A GhaliM A Moskowitz
Oct 9, 1998·Obstetrics and Gynecology·K M NewtonL A Anderson
Apr 1, 1997·Controlled Clinical Trials·T HokkanenR Tuimala
May 19, 2001·Maturitas·Y T van der Schouw, D E Grobbee
Dec 22, 1999·Maturitas·F ChiaffarinoV Chiantera
Jul 1, 1995·Journal of Biosocial Science·P Topo, E Hemminki
Aug 1, 1997·Journal of Women's Health·K M NewtonL A Anderson
Mar 1, 1997·British Journal of Obstetrics and Gynaecology·T MoorheadM Warskyj
Jun 10, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·D KuhM Wadsworth
Feb 28, 2004·BMJ : British Medical Journal·Klim McPherson, Elina Hemminki
Mar 21, 2003·Journal of Epidemiology and Community Health·L J LambertH C Bartholomew
Jan 1, 1996·International Journal of Behavioral Medicine·K FranceM Schofield
Mar 23, 2011·International Journal of Epidemiology·Yrsa A HundrupErik B Obel
Jun 5, 2014·Climacteric : the Journal of the International Menopause Society·V W Henderson
Mar 5, 2004·Expert Opinion on Pharmacotherapy·Victor W Henderson
Jan 5, 2006·Climacteric : the Journal of the International Menopause Society·D BruceP Chowienczyk
Jun 1, 1997·Journal of Psychosomatic Obstetrics and Gynaecology·J R Rueda Martinez de Santos
Jun 1, 1997·Journal of Psychosomatic Obstetrics and Gynaecology·E Hemminki, P Topo
Dec 6, 2000·Medical Care Research and Review : MCRR·T C GallagherF Comite
Oct 27, 2004·Endocrinology and Metabolism Clinics of North America·Susan D ReedAndrea Z Lacroix
Apr 4, 2002·Scandinavian Journal of Public Health·Yrsa A HundrupJohn Philip
Feb 9, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·F R RosendaalJ P Vandenbroucke
Oct 16, 1999·Annals of Internal Medicine·S E McNagny
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·F R RosendaalF M Helmerhorst
Oct 16, 1999·Journal of the American Geriatrics Society·D C SteffensJ C Breitner
Mar 19, 2004·Cadernos de saúde pública·Renata Nunes AranhaClaudia S Lopes
Aug 23, 2000·Scandinavian Journal of Public Health·E Hemminki
Aug 1, 1995·Australian Journal of Public Health·J M ShelleyL Dennerstein
Jun 22, 2007·Menopause : the Journal of the North American Menopause Society·Fabio Parazzini, UNKNOWN Progetto Menopausa Italia Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.